MarketScreener Strategies Altimmune, Inc.
Equities
ALT
US02155H2004
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.240 USD | 0.00% |
|
+5.47% | +17.45% |
| 01-05 | Altimmune, Inc. Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH | CI |
| 01-05 | Altimmune Says US FDA Grants Breakthrough Therapy Designation for Pemvidutide in MASH | MT |
MarketScreener Strategies
Search
No results for this search
- Stock Market
- Equities
- ALT Stock
- News Altimmune, Inc.
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition